IMMX
Price
$3.98
Change
-$0.05 (-1.24%)
Updated
Dec 2, 04:59 PM (EDT)
Capitalization
135.32M
One day until earnings call
Intraday BUY SELL Signals
REVB
Price
$0.92
Change
-$0.04 (-4.17%)
Updated
Dec 2, 04:59 PM (EDT)
Capitalization
5.66M
Intraday BUY SELL Signals
Interact to see
Advertisement

IMMX vs REVB

Header iconIMMX vs REVB Comparison
Open Charts IMMX vs REVBBanner chart's image
Immix Biopharma
Price$3.98
Change-$0.05 (-1.24%)
Volume$3.5K
Capitalization135.32M
Revelation Biosciences
Price$0.92
Change-$0.04 (-4.17%)
Volume$2.23K
Capitalization5.66M
IMMX vs REVB Comparison Chart in %
IMMX
Daily Signal:
Gain/Loss:
REVB
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
IMMX vs. REVB commentary
Dec 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMMX is a Hold and REVB is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 03, 2025
Stock price -- (IMMX: $3.97 vs. REVB: $0.95)
Brand notoriety: IMMX and REVB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMMX: 82% vs. REVB: 20%
Market capitalization -- IMMX: $135.32M vs. REVB: $5.66M
IMMX [@Biotechnology] is valued at $135.32M. REVB’s [@Biotechnology] market capitalization is $5.66M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMMX’s FA Score shows that 0 FA rating(s) are green whileREVB’s FA Score has 2 green FA rating(s).

  • IMMX’s FA Score: 0 green, 5 red.
  • REVB’s FA Score: 2 green, 3 red.
According to our system of comparison, REVB is a better buy in the long-term than IMMX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMMX’s TA Score shows that 2 TA indicator(s) are bullish while REVB’s TA Score has 6 bullish TA indicator(s).

  • IMMX’s TA Score: 2 bullish, 6 bearish.
  • REVB’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, REVB is a better buy in the short-term than IMMX.

Price Growth

IMMX (@Biotechnology) experienced а -7.67% price change this week, while REVB (@Biotechnology) price change was +12.80% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.91%. For the same industry, the average monthly price growth was -4.84%, and the average quarterly price growth was +52.68%.

Reported Earning Dates

IMMX is expected to report earnings on Dec 03, 2025.

Industries' Descriptions

@Biotechnology (-1.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMMX($135M) has a higher market cap than REVB($5.66M). IMMX YTD gains are higher at: 83.636 vs. REVB (-95.723). REVB has higher annual earnings (EBITDA): -8.08M vs. IMMX (-23.58M). IMMX has more cash in the bank: 11.6M vs. REVB (5.17M). REVB has less debt than IMMX: REVB (0) vs IMMX (1.04M). IMMX (0) and REVB (0) have equivalent revenues.
IMMXREVBIMMX / REVB
Capitalization135M5.66M2,384%
EBITDA-23.58M-8.08M292%
Gain YTD83.636-95.723-87%
P/E RatioN/A0.01-
Revenue00-
Total Cash11.6M5.17M224%
Total Debt1.04M0-
TECHNICAL ANALYSIS
Technical Analysis
IMMXREVB
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
68%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
59%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
70%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
59%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 9 days ago
84%
Bullish Trend 5 days ago
70%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
IMMX
Daily Signal:
Gain/Loss:
REVB
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MAPS0.870.01
+0.59%
WM Technology
CDIO2.900.01
+0.35%
Cardio Diagnostics Holdings Inc.
ALB128.14-0.19
-0.15%
Albemarle Corp
KROS16.83-0.35
-2.04%
Keros Therapeutics
TERN25.79-1.74
-6.32%
Terns Pharmaceuticals

IMMX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMMX has been loosely correlated with PRQR. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if IMMX jumps, then PRQR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMMX
1D Price
Change %
IMMX100%
-4.94%
PRQR - IMMX
36%
Loosely correlated
-9.19%
CNTA - IMMX
36%
Loosely correlated
-1.86%
CMMB - IMMX
34%
Loosely correlated
+0.38%
IMTX - IMMX
33%
Loosely correlated
-3.93%
ARQT - IMMX
32%
Poorly correlated
-0.98%
More